These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36358739)

  • 1. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation May Be a New Treatment Modality for Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Huang Y; Xu L; Wu J; Han F; Jiang H; Zheng P; Xu D; Zhang Y
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
    Front Oncol; 2021; 11():758552. PubMed ID: 34745996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
    Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
    World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
    Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; Meijerink MR; van den Tol MP
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.
    Chen FL; Wang YY; Liu W; Xing BC
    Front Oncol; 2022; 12():973418. PubMed ID: 36132151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 7. Multielectrode Radiofrequency Ablation for Resectable Metachronous Liver Metastasis from Colorectal Cancer.
    Cheng HY; Huang KW; Liang JT; Lin BR; Huang J; Hung JS; Chen CL
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
    Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases.
    Kim KH; Yoon YS; Yu CS; Kim TW; Kim HJ; Kim PN; Ha HK; Kim JC
    J Korean Surg Soc; 2011 Jul; 81(1):25-34. PubMed ID: 22066097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
    Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
    Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
    Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
    Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.
    van de Geest TW; van Amerongen MJ; Nierop PMH; Höppener DJ; Grünhagen DJ; Moelker A; Fütterer JJ; Verhoef C; de Wilt JHW
    Eur J Surg Oncol; 2022 Jun; 48(6):1368-1374. PubMed ID: 35078702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
    Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
    World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
    Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
    Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.
    Wu H; Liu GJ; Zhang ZY; Wu W; Meng YF; Wang S; Yang W; Yan K
    Int J Hyperthermia; 2021; 38(1):633-639. PubMed ID: 33882789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.
    He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological outcomes of neoadjuvant chemotherapy in patients with resectable synchronous colorectal liver metastasis: A result from a propensity score matching study.
    Jiang YJ; Zhou SC; Chen JH; Liang JW
    Front Oncol; 2022; 12():951540. PubMed ID: 36330479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation.
    Canseco LM; Liu YW; Lu CC; Lee KC; Chen HH; Hu WH; Tsai KL; Yang YH; Wang CC; Hung CH
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China.
    Chen Q; Li C; Yang H; Zhao H; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):317-323. PubMed ID: 30447909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.